Lifeline Scientific (LSE:LSI) EBIT : £5.17 Mil (TTM As of Jun. 2016)

View and export this data going back to . Start your Free Trial

What is Lifeline Scientific EBIT?

Lifeline Scientific's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2016 was £1.42 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2016 was £5.17 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Lifeline Scientific's annualized ROC % for the quarter that ended in Jun. 2016 was 12.41%. Lifeline Scientific's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2016 was 29.16%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Lifeline Scientific's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2016 was 19.37%.

Lifeline Scientific EBIT Historical Data

The historical data trend for Lifeline Scientific's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifeline Scientific EBIT Chart

Lifeline Scientific Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

EBIT

Get a 7-Day Free Trial

1.60

0.08

1.19

1.54

3.83

Lifeline Scientific Semi-Annual Data
	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16
EBIT	Get a 7-Day Free Trial										-	1.54	0.09	3.74	1.42

Competitive Comparison of Lifeline Scientific's EBIT

For the Medical Devices subindustry, Lifeline Scientific's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lifeline Scientific's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lifeline Scientific's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Lifeline Scientific's EV-to-EBIT falls into.

Lifeline Scientific EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2016 adds up the semi-annually data reported by the company within the most recent 12 months, which was £5.17 Mil.

Lifeline Scientific (LSE:LSI) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Lifeline Scientific's annualized ROC % for the quarter that ended in Jun. 2016 is calculated as:

	ROC % (Q: Jun. 2016 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2015 )	+	Invested Capital (Q: Jun. 2016 ))	/ count )
=	2.846 * ( 1 - 4.15% )	/	( (21.193	+	22.768)	/ 2 )
=	2.727891	/	21.9805
=	12.41 %

where

	Invested Capital		(Q: Dec. 2015 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	27.868	-	2.062	-	( 4.613	-	max(0, 4.007	-	15.575	+	4.613	))
=	21.193

	Invested Capital		(Q: Jun. 2016 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	30.398	-	2.368	-	( 5.262	-	max(0, 3.826	-	16.873	+	5.262	))
=	22.768

Note: The Operating Income data used here is two times the semi-annual (Jun. 2016) data.

2. Joel Greenblatt's definition of Return on Capital:

Lifeline Scientific's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2016 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2016 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2015		Q: Jun. 2016
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	2.848	/	( ( (2.378 + max(6.966, 0))	+	(2.391 + max(7.796, 0)) )	/	2 )
=	2.848	/	( ( 9.344	+	10.187 )	/	2 )
=	2.848	/	9.7655
=	29.16 %

where Working Capital is:

	Working Capital		(Q: Dec. 2015 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(6.548	+	3.392	+	1.022)	-	(2.062	+	0	+	1.934)
=	6.966

	Working Capital		(Q: Jun. 2016 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(5.816	+	4.778	+	1.017)	-	(2.368	+	0	+	1.447)
=	7.796

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2016) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Lifeline Scientific's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2016 )
	=	5.165	/	26.666
	=	19.37 %

Lifeline Scientific EBIT Related Terms

Thank you for viewing the detailed overview of Lifeline Scientific's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Lifeline Scientific (LSE:LSI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifeline Scientific Inc (LSE:LSI) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.lifeline-scientific.com

Lifeline Scientific Inc was incorporated on October 1, 1998. The Company is in the business of delivering, to targeted medical markets, a portfolio of related proprietary technologies, which include devices, solutions, and protocols designed to maximize the use and availability of organs, tissues, and cells. It serves the kidney transplant market today with its LifePort product line, and also sells solutions to service the broader organ transplant industry. The Company operates in North America, Brazil, China and Rest of World.